Concepedia

Stephen D. Gabriel

SD

3

Publications

78

Citations

3

H-Index

2008

Active since

Affiliations

Roche (United States)(Current)

Stephen D. Gabriel is an author at Roche (United States) specializing in drug discovery, natural sciences, and medicine.

Top concepts

Publications per year

2008–2012

3

Publications

3

Discovery of Highly Selective and Orally Active Lysophosphatidic Acid Receptor-1 Antagonists with Potent Activity on Human Lung Fibroblasts

Yimin Qian, Matthew J. Hamilton, Achyutharao Sidduri et al. · Journal of Medicinal Chemistry · 2012 · 54 citations · Full text

, , +20

Synthesis, SAR and evaluation of [1,4′]-bipiperidinyl-4-yl-imidazolidin-2-one derivatives as novel CCR5 antagonists

David M. Rotstein, Stephen D. Gabriel, Nicole Manser et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 12 citations · Full text

, , +6

Discovery of a potent, selective and orally bioavailable 3,9-diazaspiro[5.5]undeca-2-one CCR5 antagonist

Hanbiao Yang, Xiao‐Fa Lin, Fernando Padilla et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 12 citations · Full text

, , +8

Rows per page

1–3 of 3